EFFECT: A randomized phase II study to evaluate the EFficacy and impact on Function of two different doses of nab-paclitaxEl in elderly patients with advanCed breasT cancer
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
Price : $35 *
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms EFFECT
- 09 Jan 2018 Status changed from active, no longer recruiting to completed.
- 31 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Sep 2017.
- 02 Feb 2017 Planned End Date changed from 1 Apr 2017 to 1 Dec 2017.